slide 1

Back to the List of the Granted Patents                                                Click here to download AP2203 PDF

(11)    Patent No :    AP 2203   
(21)    Application No :    AP/P/2005/003291   
(22)    Filing Date :    23.09.2003   
(24)    Date of Grant &    31.01.2011   
           
(45)    Publication :

(30)  Priority Data       
(33) Country    (31) Number    (32) Date
US    60/412,797    24.09.2002

(84)    Designated State

BW    GM    GH    KE    LS    MW  MZ   NA   SL
SD    SZ    T Z    UG    ZM    ZW
 
(73) Applicant(s)

FRONTIER BIOTECHNOLOGIES CO., LTD, 3rd Floor, Building 1, 70 Keyuan 4th Street, Bio- Garden, High Tech Zone, Chongqing,

Peoples Republic of China

(72) Inventors

XIE Dong, United States of America

JIANG He, United States of America

(74) Representative

HONEY & BLANCKENBERG
 

(51)  International  Classification   C07K 14/16 (2006.01)    A61K 38/00 (2006.01)
C07K 14/005 (2006.01)   


(54)    Title

Peptide derivative fusion inhibitors of HIV infection

(57)    Abstract

This invention relates to gp41 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, this invention relates to gp41 derivatives having inhibiting activity against human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) with enhanced duration of action for the treatment of the respective viral infections.

(56)    Documents Cited :    WO 00/69911 A    WO 00/69902 A

Newsletter

Join our newsletter for CIPIT news through subscriptions!

SEND

Social Media

 

    

Contact Us

TEL : (254) 703 034 612